decanoylcarnitine | 14760-75-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: decanoylcarnitine
• 英文别名: dl-O-Decanoylcarnitin-Kation；Decyl-carnitin；Decanoyl-DL-carnitine；(3-carboxy-2-decanoyloxypropyl)-trimethylazanium
• CAS: 14760-75-9
• 化学式: C₁₇H₃₄NO₄
• 分子量: 316.461
• InChiKey: LZOSYCMHQXPBFU-UHFFFAOYSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  22
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
  申请人：Kõster Hubert

  公开号：US20100248264A1

  公开（公告）日：2010-09-30

  Capture compounds and collections thereof and methods using the compounds for the analysis of biomolecules are provided. In particular, collections, compounds and methods are provided for analyzing complex protein mixtures, such as the proteome. The compounds are multifunctional reagents that provide for the separation and isolation of complex protein mixtures. Automated systems for performing the methods also are provided.

  提供了捕获化合物及其集合以及使用这些化合物进行生物分子分析的方法。特别地，提供了用于分析复杂蛋白质混合物（如蛋白质组）的集合、化合物和方法。这些化合物是多功能试剂，可用于分离和分离复杂的蛋白质混合物。还提供了执行这些方法的自动化系统。
• MEDIUM-CHAIN FATTY ACYLS AND PHOSPHOLIPIDS AS BIOMARKERS FOR CARDIOVASCULAR DISEASES
  申请人：Eberhard-Karls-Universität Tübingen

  公开号：EP4043884A1

  公开（公告）日：2022-08-17

  The present invention relates to the use of lipid compounds comprising at least one medium chain fatty acid as biomarkers for diseases which are due to or accompanied by fatty acid oxidation disorder. The present invention furthermore relates to methods of assessing the risk to develop said diseases by determining the lipid compounds in samples.

  本发明涉及将包含至少一种中链脂肪酸的脂质化合物作为生物标志物，用于检测由脂肪酸氧化紊乱引起或伴随的疾病。本发明还涉及通过测定样本中的脂质化合物来评估罹患上述疾病风险的方法。
• [EN] MEDIUM-CHAIN FATTY ACYLS AND PHOSPHOLIPIDS AS BIOMARKERS FOR CARDIOVASCULAR DISEASES<br/>[FR] ACYLES GRAS À CHAÎNE MOYENNE ET PHOSPHOLIPIDES UTILISÉS EN TANT QUE BIOMARQUEURS POUR DES MALADIES CARDIOVASCULAIRES
  申请人：[en]EBERHARD KARLS UNIVERSITÄT TÜBINGEN

  公开号：WO2022171763A1

  公开（公告）日：2022-08-18

  The present invention relates to the use of lipid compounds comprising at least one medium chain fatty acid as biomarkers for diseases which are due to or accompanied by fatty acid oxidation disorder. The present invention furthermore relates to methods of assessing the risk to develop said diseases by determining the lipid compounds in samples.